Search Results
The Genomics Landscape
In the April 2019 edition of The Genomics Landscape, NHGRI Director Eric Green previews the redesigned genome.gov website and its new features.
… Rob Stein GDPR: Crossing the Data Sharing Bridge, One Regulation at a Time Genome: Unlocking Life's Code March 2019 …
The Genomics Landscape
In the November 2023 edition of The Genomics Landscape, NHGRI Director Eric Green, celebrates the 30th anniversary of the NHGRI Intramural Research Program as well as announces the launch of a new digital history archive.
… at the University of Chicago highlight tissue-specific regulation of genes that lead to differences between … understanding of evolution as well as the role of genomic regulation in human traits. This research was funded by the …
File
… The Food and Drug Administration’s (FDA) Oversight and Regulation of Laboratory Developed Tests (LDTs) …
Fact Sheet
Sickle cell disease resources for healthcare providers
… suspension DailyMed, National Library of Medicine FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease Casgevy FDA Lovotibeglogene autotemcel Lovotibeglogene autotemcel … suspension DaliyMed, National Library of Medicine FDA Approves First Gene Therapies to Treat Patients with …
The Genomics Landscape
In the November 2019 edition of The Genomics Landscape, NHGRI Director Eric Green highlights the International Common Disease Alliance's scientific plenary and launch meeting in September, which included an international panel on opportunities emerging outside the U.S., North America, and Europe; discussions about polygenic risk scores; and an overview about data platforms, data sharing, and ethics.
… diversity in health-related research” NIH & NHGRI News FDA approves new breakthrough therapy for cystic fibrosis …
Fact Sheet
Sickle cell disease resources for patients
… What is Gene Therapy? U.S. Food and Drug Administration (FDA) Gene Therapies for Sickle Cell Disease Cure Sickle … suspension DailyMed, National Library of Medicine FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease Casgevy FDA Lovotibeglogene autotemcel Lovotibeglogene autotemcel …
News Release
NIH awards more than $64 million to for a database of human cellular responses called the Library of Integrated Network-based Cellular Signatures or LINCS.
… will leverage the U.S. Food and Drug Administration's (FDA) Adverse Event Reporting System database to identify … from human skin cells. Such signatures may help repurpose FDA-approved drugs to lessen adverse events and help in …
Clinical Research
The Institutional Review Board (IRB) is responsible for protecting the rights and welfare of the human subjects of research protocols that are conducted by intramural investigators in NHGRI and a number of other institutes.
… (OHRP) OHRP Approved Federal-Wide Assurances (FWAs) FDA Guidance for IRBs, Clinical Investigators and Sponsors FDA Investigator-Initiated Investigational New Drug (IND) …
Staff
Dr. Michael Erdos is an Associate Investigator in the Molecular Genetics Section of the Center for Precision Health Research.
… treatment strategies are in the application process for FDA approval. In the context of complex genetic disease, Dr. … stiffness, and ultimately a modest extension in lifespan. FDA approved lonafarnib (a farnesyltransferase inhibitor) for … the Progeria Research Foundation application with the FDA for treatment of HGPS children with antisense oligomers. …
The Genomics Landscape
In the March 2018 edition of The Genomics Landscape, NHGRI Director Eric Green highlights a strategic planning effort to establish a 2020 vision for genomics.
… Opportunities Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) - Parent … Applications Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer (STTR) - Parent …